NCT01362491COMPLETEDanonymous

Ibuprofen Sodium Tension Headache Study

Sponsor

Source record

Pfizer

Phase

Source record

PHASE3

Modality

AI-normalized

small molecule

Target

AI-normalized

Ibuprofen Sodium, Standard Ibuprofen, Placebo

Indication / condition

AI-normalized

Pain

Intervention

Source record

Ibuprofen Sodium, Standard Ibuprofen, Placebo

Related intelligence directories

Indication directory: Pain Modality directory: small molecule Target directory: Ibuprofen Sodium

Source & freshness

Source record

NCT ID

NCT01362491

Original source

ClinicalTrials.gov

Source last updated

Jul 30, 2014

Ingested at

Jun 09, 2026

Internal sync

Jun 09, 2026

Model version

trialsignal-ai-v1

Normalized confidence

96%

Validation status

validated

Open original registry record

View original source fields

NCT ID

NCT01362491

Title

Ibuprofen Sodium Tension Headache Study

Sponsor

Pfizer

Status

COMPLETED

Phase

PHASE3

Condition raw

Pain

Condition normalized

Pain

Modality raw

small molecule

Modality normalized

small molecule

Target raw

Ibuprofen Sodium, Standard Ibuprofen, Placebo

Target normalized

Ibuprofen Sodium, Standard Ibuprofen, Placebo

Interventions

Ibuprofen Sodium, Standard Ibuprofen, Placebo

Public preview

Source record

This study will compare the ability of a single-dose of a novel ibuprofen formulation to relieve pain compared to placebo and standard ibuprofen in the treatment of tension-type headache

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Early access offer

Subscribe with code FOUNDERS5 for a 5-day premium trial.

Full protocol, outcomes, eligibility, contacts and results sections

Patent/IP landscape with verified records when available

Board-ready PDF export with source provenance

Save to folders and synthesize multiple assets in premium workspace

Create account

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

Ibuprofen Sodium Tension Headache Study

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 20, 2026

NCT ID

NCT01362491

Status

COMPLETED

Phase

PHASE3

Sponsor

Pfizer

Executive brief

Investment-Ready Snapshot

This study will compare the ability of a single-dose of a novel ibuprofen formulation to relieve pain compared to placebo and standard ibuprofen in the treatment of tension-type headache

Source & freshness

Provenance

SourceClinicalTrials.gov

Source updatedJul 30, 2014

Internal syncJun 09, 2026

Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT01362491

Indication

Pain

Modality

small molecule

Target

Ibuprofen Sodium, Standard Ibuprofen, Placebo

Intervention

Ibuprofen Sodium, Standard Ibuprofen, Placebo

Source record

Protocol Description

Detailed source ingestion pending.

Source record

Outcome Measures

Detailed source ingestion pending.

Source record

Eligibility

Detailed source ingestion pending.

AI analysis

Known Results And Readout Context

Detailed source ingestion pending.

IP intelligence

Patent And IP Landscape

Detailed source ingestion pending.

Source record

Contacts

Detailed source ingestion pending.